Title: Drug Products or Categories of Drug Products That Present Demonstrable Difficulties for Compounding Under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act
Agency/Subagency: 0910-HHS/FDA
Stage of Rulemaking: Proposed Rule Stage
Meeting Date/Time: 09/19/2023 03:30 PM
Requestor: American Pharmacists Association Requestor's Name: Michael Baxter Requestor's Client: Compounding Core Group